Healthcare

As the Healthcare sector emerges from a time of immense pressure and high visibility, we see huge investment, potential and opportunity ahead

Truly dynamic and innovative at its core, Healthcare is poised for a period of growth and transformation. Driven by a range of factors – including Covid-19; greater emphasis on personalisation; digitisation and technological innovation; changing demographics; and shifting customer and patient expectations – organisations of all sizes and ownership structures seek the right leaders to seize this opportunity.

Supporting clients at Board, Executive Committee and leadership levels, we combine extensive experience in and a deep understanding of the wide and varied Healthcare sector, including its clinical leadership, as well as access to relevant talent pools in adjacent consumer-facing industries.

View current opportunities

The MBS Group acts as an advisor to NHS and other public sector bodies on senior appointments. To view current appointments, click here.

Our Experience

Clinical Services

Life Sciences
HealthTech & Digital Healthcare
Insurers
Healthcare Systems
Medical Devices & Diagnostics

Selected Clients

Latest MBS News & Intelligence

Well Pharmacy launches Online Doctor service. The independent pharmacy chain has launched a new Online Doctor service in partnership with Expert Health, offering fast access to prescription treatments without in-person consultations. Prescriptions can be received via home delivery or collected.
AstraZeneca sees revenues surge. The pharmaceuticals maker saw total revenues rise 21% to $54.1bn throughout 2024, while earnings rose 19%. It will target revenue of $80bn by the end of the decade.
GSK raises outlook. The pharmaceutical company has upped its 2031 sales outlook to over £40bn, up from £38bn. Total 2024 sales were 31.4bn which was an increase of 3%, while core operating profit rose 11%. CEO Emma Walmsley categorised it as a “year of excellent performance”.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.